Rocuronium Injection Market

Rocuronium injection is an adjuvant drug for general anesthesia, which is used to routinely induce tracheal intubation during anesthesia and maintain skeletal muscle relaxation during surgery. As with other muscle relaxants, rocuronium bromide injections should be dosed individually.

Rocuronium Injection Market contains market size and forecasts of Rocuronium Injection in global, including the following market information:

Global Rocuronium Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Rocuronium Injection Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Rocuronium Injection companies in 2021 (%)

The global Rocuronium Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

5ml/vial Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Rocuronium Injection include Athenex, AuroMedics, Fresenius Kabi, Mylan, Pfizer, Sagent, Sandoz, X-Gen Pharmaceutical and Baxter. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Rocuronium Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Rocuronium Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Rocuronium Injection Market Segment Percentages, by Type, 2021 (%)

• 5ml/vial
• 10ml/vial

Global Rocuronium Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Rocuronium Injection Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Special Clinic
• Recovery Center

Global Rocuronium Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Rocuronium Injection Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Rocuronium Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Rocuronium Injection revenues share in global market, 2021 (%)
• Key companies Rocuronium Injection sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Rocuronium Injection sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Athenex
• AuroMedics
• Fresenius Kabi
• Mylan
• Pfizer
• Sagent
• Sandoz
• X-Gen Pharmaceutical
• Baxter